We are thrilled to be featured in Pharmaceutical Online, where our expert insights on GDUFA and facility readiness are shaping the conversation around generic drug approvals. Our thought leadership in regulatory affairs continues to empower the pharmaceutical industry, ensuring streamlined compliance and market success. Read our latest guest column by Ravali Patlolla to explore how GDUFA III is transforming the ANDA submission process.
Click here to read the complete "Pharmaceutical Online" Issue.